Sesen Bio Inc reports results for the quarter ended in March - Earnings Summary

Carisma Therapeutics

09/05/2022 15:07

* Sesen Bio Inc  SESN.OQ  reported quarterly breakeven
results​​
per share for the quarter ended in March. The mean expectation
of three analysts for the quarter was for a loss of 10 cents per
share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Sesen Bio Inc's reported EPS for the quarter was breakeven
results​.
    * The mean earnings estimate of analysts had fallen by
about 100%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sesen Bio Inc shares had fallen by 10.7% this quarter and
lost 34.0% so far this year.
    * The company reported a quarterly loss of $807 thousand.
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$1.85 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 02:06 p.m.  ​All
figures in US dollars unless otherwise stated